Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Teleflex IncorporatedNYSE: TFX

Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026

Deferred revenue remains negative

Q2 FY2026 deferred revenue was $0, compared with $0 a year earlier.

Context

  • Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoJun 2025
$0— since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Revenue vs competitors

How TFX compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred revenue is compared through growth and share of total assets rather than absolute size.
  • Deferred revenue amounts to 0.0% of total assets for TFX, versus a peer median of 0.0%.
TFX Competitors
Deferred Revenue for TFX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ARWRArrowhead Pharmaceuticals, Inc.Sep 2026$91.65M USD+3720.3%+373.0%5.3%
KRYSKrystal Biotech, Inc.Jun 2026$83.48M USD——5.6%
STVNStevanato Group S.p.A.Jun 2026€44.47M EUR+25.6%-6.7%1.7%
TGTXTG Therapeutics, Inc.Sep 2026$26.1M USD-1.1%—1.6%
PTCTPTC Therapeutics, Inc.Jun 2026$1.19M USD-87.8%+14.7%0.0%
TFXTeleflex IncorporatedJun 2026$0 USD——0.0%
PCVXVaxcyte, Inc.Jun 2026$0 USD——0.0%
ALKSAlkermes plcSep 2026$0 USD——0.0%
BLCOBausch + Lomb CorporationJun 2026$0 USD——0.0%
MMSIMerit Medical Systems, Inc.Sep 2026$0 USD———
CRSPCRISPR Therapeutics AGSep 2026$0 USD-100.0%—0.0%
Peer median (excluding TFX) —-1.1%+14.7%0.0%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents445.08M292.03M222.85M290.19M393.26M
Short-term Investments00015.97M0
Net Receivables383.57M408.83M443.47M459.5M345.58M
Inventory477.64M578.51M626.22M600.13M404.4M
Other Current Assets117.28M125.08M107.47M101.88M775.53M
Total Current Assets1.43B1.41B1.41B1.47B1.94B
Property, Plant & Equipment (Net)573.41M578.42M603.43M611.76M590.1M
Goodwill2.5B2.54B2.91B2.63B2.31B
Intangible Assets2.29B2.31B2.5B2.27B1.52B
Long-term Investments011.91M0011.19M
Tax Assets6.82M6.4M6.75M11.37M12.59M
Other Non-current Assets69.1M77.46M98.94M102.62M565.82M
Total Non-current Assets5.44B5.52B6.13B5.63B5.01B
Total Assets6.87B6.93B7.53B7.1B6.95B
Account Payables118.24M126.81M132.25M141.03M130.2M
Short-term Debt110M87.5M87.5M100M100M
Tax Payables83.94M24.74M41.45M41.32M18.79M
Deferred Revenue00000
Other Current Liabilities55.63M63.38M46.55M68.54M388.27M
Total Current Liabilities680.12M581.49M606.75M649.36M762.03M
Long-term Debt1.74B1.62B1.73B1.56B2.54B
Deferred Tax Liabilities370.12M388.89M456.08M391.07M183.75M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities210.6M191.26M189.86M124.32M251.04M
Total Non-current Liabilities2.44B2.32B2.48B2.17B3.06B
Total Liabilities3.12B2.91B3.09B2.82B3.82B
Common Stock47.93M47.96M48.05M48.1M48.2M
Retained Earnings3.52B3.82B4.11B4.12B3.15B
Accumulated OCI(346.96M)(403.52M)(314.41M)(316.67M)(239.47M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.75B4.02B4.44B4.28B3.12B
Total Debt1.97B1.83B1.93B1.76B2.73B
Net Debt1.52B1.54B1.7B1.46B2.33B

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.